{"id":"W3208834979","doi":"10.1016/j.jtho.2021.08.015","title":"EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC","year":2021,"lang":"en","type":"editorial","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Gefitinib; Erlotinib; Medicine; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Oncology; Protein kinase domain; Mutant; EGFR inhibitors; Internal medicine; Exon; Adenocarcinoma; Mutation; Epidermal growth factor receptor; Gene; Cancer; Receptor; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006503466,0.002863506,0.003905858,0.001760342,0.002004323,0.004891898,0.002593692,0.01451585,0.00780416],"category_scores_gemma":[0.01696552,0.000995092,0.002592825,0.0009384606,0.001447478,0.003174882,0.0007854399,0.02543099,0.007689921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002552903,"about_ca_system_score_gemma":0.002671508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001542113,"about_ca_topic_score_gemma":0.004901018,"domain_scores_codex":[0.996926,0.0005500223,0.0004375029,0.0002980923,0.001576121,0.000212338],"domain_scores_gemma":[0.9844896,0.006603516,0.0009565692,0.0003227733,0.004861887,0.002765729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001227306,0.00002882229,0.00004693415,0.0002821638,0.00004230663,0.0001128035,0.000005816055,0.00004615775,0.00007287267,0.0002428994,0.9875888,0.0114077],"study_design_scores_gemma":[0.0004167742,0.0001731219,0.001228034,0.0008493627,0.0002782695,0.0004693741,0.00004398562,0.000584692,0.0002760474,0.001678649,0.9939519,0.00004976429],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00005638814,0.004687717,0.0001085383,0.03675866,0.9567993,0.00001753832,0.00005314425,0.00004954794,0.001469089],"genre_scores_gemma":[0.0004625178,0.004135882,0.0001028053,0.02552595,0.9642772,0.00001542006,0.00003245724,0.00001889624,0.005428789],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01451585,"threshold_uncertainty_score":0.03439403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02300321274282717,"score_gpt":0.4435151527630709,"score_spread":0.4205119400202437,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}